AbbVie, Lilly-backed Capsida cuts staff months after signing Big Pharma deals

AAV-focused gene therapy maker Capsida Biotherapeutics is laying off staff, the company confirmed to Fierce Biotech. The cuts could impact as much as 25% of the team, a source familiar with the decision said.